A detailed history of Atticus Wealth Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Atticus Wealth Management, LLC holds 4,086 shares of BSX stock, worth $419,591. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,086
Previous 1,795 127.63%
Holding current value
$419,591
Previous $192,000 107.29%
% of portfolio
0.11%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$97.03 - $108.14 $222,295 - $247,748
2,291 Added 127.63%
4,086 $398,000
Q2 2025

Jul 10, 2025

BUY
$89.7 - $107.41 $161,011 - $192,800
1,795 New
1,795 $192,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Atticus Wealth Management, LLC Portfolio

Follow Atticus Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atticus Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atticus Wealth Management, LLC with notifications on news.